Ibaraki, Japan

Satomi Nishijima

This inventor holds 1 USPTO granted patent. Top assignee: Yamanouchi Pharmaceutical Company Ltd.. Active years: 2001.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Satomi Nishijima

Introduction

Satomi Nishijima is a notable inventor based in Ibaraki, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in developing compositions that lower cholesterol levels. Her work is essential in addressing health issues related to cholesterol, which is a critical factor in cardiovascular diseases.

Latest Patents

Satomi Nishijima holds a patent for "Medicinal compositions with cholesterol-lowering effect." This patent describes pharmaceutical compositions that contain a compound with a PPAR (peroxisome proliferator-activated receptor) δ activating effect or a combination of PPAR δ and PPAR γ activating effects. The compositions are designed to lower LDL cholesterol levels effectively. The patent also outlines a method for identifying compounds with cholesterol-lowering effects by measuring their PPAR δ-activating effects.

Career Highlights

Nishijima's career is marked by her dedication to pharmaceutical research and development. She works at Yamanouchi Pharmaceutical Company Ltd., where she collaborates with other talented professionals in the field. Her innovative approach to medicinal compositions has garnered attention and respect within the scientific community.

Collaborations

Some of her notable coworkers include Teruhiko Shimokawa and Yuichi Iizumi. Their collaborative efforts contribute to the advancement of research in cholesterol-lowering medications.

Conclusion

Satomi Nishijima's work in developing cholesterol-lowering pharmaceutical compositions showcases her innovative spirit and commitment to improving health outcomes. Her contributions are vital in the ongoing battle against cardiovascular diseases, making her a significant figure in the field of pharmaceuticals.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…